Concepedia

Author

Chelsea Bolyard

The Ohio State University

Also Known As

Bolyard, Chelsea, C Bolyard, C. Bolyard, Chelsea Bolyard, Chelsea M Bolyard, Chelsea M. Bolyard

112

Publications

1.2K

Citations

19

H-Index

20

Concepts

All Affiliations

The Ohio State UniversityThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteThe Ohio State University Wexner Medical CenterNeurological SurgeryNationwide Children's Hospital
CB

About

Chelsea Bolyard is an author at The Ohio State University specializing in cell biology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

197

2

Cell Biology

3

3

197

3

Immunology

2

2

85

4

Pathology

1

1

43

5

Autoimmunity

1

1

42

Chelsea Bolyard

×

15

Publications

745

Citations

15

H-Index

YearCitations

Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target

U. Saini, Srikanth I. Naidu, Adam C. ElNaggar,

Oncogene

2016

112

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment

Walter H. Meisen, Eric S. Wohleb, Alena Cristina Jaime‐Ramirez,

Clinical Cancer Research

2015

94

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Ji Young Yoo, Alena Cristina Jaime‐Ramirez, Chelsea Bolyard,

Clinical Cancer Research

2016

85

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Ji Young Yoo, Brian Hurwitz, Chelsea Bolyard,

Clinical Cancer Research

2014

75

Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide

Alena Cristina Jaime‐Ramirez, Nina Dmitrieva, Ji Young Yoo,

The Journal of Gene Medicine

2017

48

Role of Cysteine-rich 61 Protein (CCN1) in Macrophage-mediated Oncolytic Herpes Simplex Virus Clearance

Amy Haseley Thorne, Walter H. Meisen, Luke Russell,

Molecular Therapy

2014

43

The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells

Hongsheng Dai, Nathaniel Griffin, Chelsea Bolyard,

Immunity

2017

42

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

No‐Joon Song, Carter Allen, Anna E. Vilgelm,

Journal of Hematology & Oncology

2022

41

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema

Bangxing Hong, Kamaldeen Muili, Chelsea Bolyard,

Molecular Therapy — Oncolytics

2018

40

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Chelsea Bolyard, Walter H. Meisen, Yeshavanth Banasavadi‐Siddegowda,

Clinical Cancer Research

2016

36

Page 1